2022
DOI: 10.1002/ibra.12080
|View full text |Cite
|
Sign up to set email alerts
|

Dyslexia with and without Irlen syndrome: A study of influence on abilities and brain‐derived neurotrophic factor level

Abstract: The presence of comorbid Irlen syndrome (IS) in children with developmental dyslexia (DD) may have an impact on their reading and cognitive abilities. Furthermore, the brain‐derived neurotrophic factor (BDNF) was reported to be expressed in brain areas involved in cognitive and visual processing. The aim of this study was to evaluate some cognitive abilities of a group of dyslexic children with IS and to measure and compare the plasma BDNF level to dyslexic children without IS and neurotypical (NT) children. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 30 publications
0
0
0
Order By: Relevance
“…Most importantly, KE ID 381 represents the brain-derived neurotrophic factor (BDNF), a key molecule necessary for healthy brain development and notably its learning and memory function. The dysregulation of BDNF was linked with numerous NDDs such as Autism Spectrum Disorder (ASD, ICD-11 6A02) (Liu et al, 2021), dyslexia (ICD-11 6A03) (Abdelraouf et al, 2023) and intellectual disability (ICD-11 6A00) (Esnafoglu and Adıgüzel, 2021), but not with Attention Deficit Hyperactivity Disorder (ADHD, ICD-11 6A05) (Mei et al, 2022;de Lucca et al, 2023). ADHD was, on the other hand, associated with impaired synaptogenesis (KE ID 385) (Dark et al, 2018;Halperin et al, 2021).…”
Section: Developmental Neurotoxicity (Dnt)mentioning
confidence: 99%
“…Most importantly, KE ID 381 represents the brain-derived neurotrophic factor (BDNF), a key molecule necessary for healthy brain development and notably its learning and memory function. The dysregulation of BDNF was linked with numerous NDDs such as Autism Spectrum Disorder (ASD, ICD-11 6A02) (Liu et al, 2021), dyslexia (ICD-11 6A03) (Abdelraouf et al, 2023) and intellectual disability (ICD-11 6A00) (Esnafoglu and Adıgüzel, 2021), but not with Attention Deficit Hyperactivity Disorder (ADHD, ICD-11 6A05) (Mei et al, 2022;de Lucca et al, 2023). ADHD was, on the other hand, associated with impaired synaptogenesis (KE ID 385) (Dark et al, 2018;Halperin et al, 2021).…”
Section: Developmental Neurotoxicity (Dnt)mentioning
confidence: 99%